SCHIERMEIER ANDREW 4
4 · Intellia Therapeutics, Inc. · Filed Dec 20, 2018
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Award
Stock Option (right to buy)
2018-12-18+81,000→ 81,000 totalExercise: $14.58Exp: 2028-12-17→ Common Stock (81,000 underlying)
Footnotes (1)
- [F1]This option was granted on December 18, 2018 with respect to 81,000 shares of Common Stock, with 25% vesting on December 18, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.